LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

CVS Health Corp.

Slēgts

SektorsVeselības aprūpe

77.86 -1.93

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

77.8

Max

78.58

Galvenie mērījumi

By Trading Economics

Ienākumi

-3.8B

-2.8B

Pārdošana

4B

103B

P/E

Sektora vidējais

204.053

105.69

EPS

1.6

Dividenžu ienesīgums

3.37

Peļņas marža

-2.722

Darbinieki

219,000

EBITDA

-4B

-1.6B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+14.78% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

3.37%

2.37%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-6.1B

98B

Iepriekšējā atvēršanas cena

79.79

Iepriekšējā slēgšanas cena

77.86

Ziņu noskaņojums

By Acuity

64%

36%

309 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

CVS Health Corp. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 29. okt. 10:48 UTC

Peļņas

CVS Posts Loss on Write-Down, Boosts Guidance as Adjusted Earnings Rise

2025. g. 30. okt. 20:45 UTC

Peļņas

Gilead Earnings Beat Expectations. The Stock Is Still Falling. -- Barrons.com

2025. g. 30. okt. 20:30 UTC

Peļņas

Gilead Earnings Beat Expectations. The Stock Is Still Falling. -- Barrons.com

2025. g. 30. okt. 14:52 UTC

Peļņas

Cigna Stock Tumbles on Margin Warning for Pharmacy Benefit Services -- Barrons.com

2025. g. 30. okt. 10:21 UTC

Peļņas

Cigna Beats Earnings Expectations. The Stock Is Facing Political Uncertainties. -- Barrons.com

2025. g. 29. okt. 20:14 UTC

Peļņas

Why CVS Buying Oak Street Health in 2023 Was One of Worst Healthcare Deals in Recent Years -- Barrons.com

2025. g. 29. okt. 16:00 UTC

Peļņas

In Medicare, Less Is Now More for Big Insurers -- Heard on the Street -- WSJ

2025. g. 29. okt. 13:31 UTC

Peļņas

CVS Posts Loss on Write-Down, Boosts Guidance -- Update

2025. g. 29. okt. 11:13 UTC

Peļņas

CVS Health Earnings Are Better Than Expected. Why the Stock Is Falling. -- Barrons.com

2025. g. 29. okt. 10:46 UTC

Peļņas

CVS Health Earnings Are Better Than Expected. Why the Stock Is Falling. -- Barrons.com

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health Raises 2025 View To Adj EPS $6.55-Adj EPS $6.65 >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Adjusted Operating Income $3.46B >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health Now Sees 2025 Cash Flow From Operations $7.5B-$8B; Had Seen at Least $7.5B >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health Posts 3Q $5.7B Goodwill Impairment Charge Related to Healthcare Delivery Unit >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Front Store Same-Store Sales Up 1.5% >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Healthcare Benefits Segment Revenue $35.99B >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Health Services Segment Revenue $49.27B >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Same-Store Sales Up 14.3% >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Pharmacy & Consumer Wellness Segment Revenue $36.21B >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Pharmacy & Consumer Wellness Segment Revenue Up 11.7% >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Pharmacy Same-Store Sales Up 16.8% >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Rev $102.87B >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Loss $3.98B >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health Sees FY Loss/Shr 34c-Loss 24c >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Healthcare Benefits Segment Revenue Up 9.1% >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health Sees FY Adj EPS $6.55-Adj EPS $6.65 >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Loss/Shr $3.13 >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health Sees FY Loss $432M-Loss $307M >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Adj EPS $1.60 >CVS

2025. g. 29. okt. 10:30 UTC

Peļņas

CVS Health 3Q Health Services Segment Revenue Up 11.6% >CVS

Salīdzinājums

Cenas izmaiņa

CVS Health Corp. Prognoze

Cenas mērķis

By TipRanks

14.78% augšup

Prognoze 12 mēnešiem

Vidējais 89.31 USD  14.78%

Augstākais 102 USD

Zemākais 75 USD

Pamatojoties uz 17 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CVS Health Corp. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

17 ratings

16

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

65.92 / 68.28Atbalsts un pretestība

Īstermiņā

Very Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bullish Evidence

Noskaņojums

By Acuity

309 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
help-icon Live chat